Scarica l'app Stockscreener
2.23
0.90%
0.02
Lexaria Bioscience Corp Azioni (LEXX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | 2023-02-28 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
4.15%
0.145
|
0.1513 | -0.00343 | 0.0932 | 0.035 |
| Cost Of Revenue |
100.00%
-
|
0.00482 | - | 0.0127 | 0.00296 |
| Gross Profit |
0.99%
0.145
|
0.1465 | -0.00343 | 0.0804 | 0.0321 |
Operating Expenses
|
36.76%
0.813
|
1.2856 | 1.0671 | 2.464 | 1.3427 |
| Benefits Costs and Expenses |
40.30%
0.7977
|
1.3363 | 1.2456 | 2.4767 | 1.3457 |
| Costs And Expenses |
40.30%
0.7977
|
1.3363 | 1.2456 | 2.4767 | 1.3457 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Depreciation and Amortization |
44.64%
0.0159
|
0.0288 | 0.0709 | 0.025 | 0.0247 |
| Operating Income/Loss |
41.36%
-0.668
|
-1.1391 | -1.102 | -2.3708 | -1.3077 |
| Net Interest Income/Expense |
100.01%
-0.000001
|
0.00732 | - | - | - |
| Interest Income/Expense After Provision For Losses |
100.01%
-0.000001
|
0.00732 | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
44.92%
-0.6527
|
-1.185 | -1.249 | -2.3836 | -1.3106 |
| Income/Loss From Continuing Operations After Tax |
44.92%
-0.6527
|
-1.185 | -1.249 | -2.3836 | -1.3106 |
|
Net Income/Loss
|
44.92%
-0.6527
|
-1.185 | -1.249 | -2.3836 | -1.3106 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
44.11%
-0.00319
|
-0.00572 | -0.0097 | -0.0121 | -0.0125 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):